Johnson & Johnson (JNJ) Total liabilities 2016–2025
Johnson & Johnson (JNJ) total liabilities at each fiscal year-end, per SEC filings.
$117.7BFY2025 · since FY2016: $70.8B → $117.7B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $117.7B | +8.3% |
| FY2024 | $108.6B | +10.0% |
| FY2023 | $98.8B | -10.7% |
| FY2022 | $110.6B | +2.4% |
| FY2021 | $108.0B | -3.2% |
| FY2020 | $111.6B | +13.6% |
| FY2019 | $98.3B | +5.4% |
| FY2018 | $93.2B | -4.1% |
| FY2017 | $97.1B | +37.2% |
| FY2016 | $70.8B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice